----
Zura Bio (ZURA)
Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develop...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
Zura Bio Analyst Rating
View moreForecast & Rating
Oct 22, 2026Price forecast
$19.00433.71%
Forecast & RatingStrong buy
7analysts
- Strong buy85.71%
- Buy14.29%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 6
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
News
Market Movers · Zura Bio surges 8% during regular trading
Global Report · Micro-Cap Crossroads: 350% Target Surges Meet Nasdaq Deadlines
benzinga_article · BKV, Lamb Weston, Penguin Solutions And Other Big Stocks Moving Higher On Wednesday
Tip Ranks · Leerink Partners Reaffirms Their Buy Rating on Zura Bio (ZURA)
Tip Ranks · 3 High-Risk/High-Reward Stocks With 100%+ Upside Potential, According to Analysts
PUBT · Zura Bio to attend Cantor Global Healthcare Conference fireside chat
